1. Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach
   Fuhai Ma et al, 2020, Journal of Cancer Research and Clinical Oncology CrossRef